Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn’s Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage

BACKGROUND/AIMS: We evaluated whether anti-Saccharomyces cerevisiae antibody (ASCA) titers are associated with diagnostic findings, disease activity, Paris classification phenotypes, and persistence after infliximab (IFX) treatment in children with Crohn’s disease (CD). We also investigated the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Jin, Kim, Eunsil, Kang, Ben, Lee, Yoon, Kang, Eun-Suk, Choe, Yon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444098/
https://www.ncbi.nlm.nih.gov/pubmed/33376230
http://dx.doi.org/10.5009/gnl20212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444098/
https://www.ncbi.nlm.nih.gov/pubmed/33376230
http://dx.doi.org/10.5009/gnl20212

Ejemplares similares